MedPath

The effect of Telmisartan on inflammatory processes in the vascular wall of abdominal aortic aneurysms.

Phase 2
Conditions
abdominal aortic aneurysm. aneurysm.
10002363
Registration Number
NL-OMON43688
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
15
Inclusion Criteria

Patients with an abdominal aortic aneurysm who are planned for elective open surgical repair.

Exclusion Criteria

1. Renal insufficiency; eGFR < 50 ml/min
2. Bloodpressure < 120/70 mmHg
3. Abnormal liver function (liver enzymes > 3 times elevated of normal value)
4. Hypersensitivity for angiotensin II type 1 receptor antagonist or ACE inhibitor
5. Current usage of angiotensin II type 1 receptor antagonist or ACE inhibitor
6. Known significant renal stenosis (>70%) of one or both renal arteries
7. Active gout

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Exploratory pathway analysis of markers for inflammation, cell proliferation<br /><br>and matrix remodeling.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>n.a.</p><br>
© Copyright 2025. All Rights Reserved by MedPath